Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

S. B. Saslow, J. S. Scolapio, M. Camilleri, L. A. Forstrom, G. M. Thomforde, D. D. Burton, J. Rubin, H. C. Pitot, A. R. Zinsmeister

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea'. Together they form a unique fingerprint.

Medicine & Life Sciences